Results from the MajesTEC-9 and CARTITUDE-4 Clinical Trials in Patients With Relapsed/Refractory Multiple Myeloma by Madaline Spencer| Published on: Jul 29, 2026

Results from the MajesTEC-9 and CARTITUDE-4 Clinical Trials in Patients With Relapsed/Refractory Multiple Myeloma by Madaline Spencer| Published on: Jul 29, 2026 Roberto Mina, MD, Assistant Professor at Winship Cancer Institute at Emory University, discusses results from the MajesTEC-9 and CARTITUDE-4 clinical trials in patients with relapsed/refractory multiple myeloma (RRMM). https://checkrare.com/results-from-the-majestec-9-and-cartitude-4-clinical-trials-in-patients-with-relapsed-refractory-multiple-myeloma/